Speakers

Smt. Anupriya Patel

Smt. Anupriya Patel is a Member of Parliament, Lok Sabha, from Mirzapur constituency in Uttar Pradesh. She was re-elected to the 18th Lok Sabha for 3rd consecutive term. She earlier represented Rohania constituency, Varanasi district in Uttar Pradesh Legislative Assembly. She has served as MoS (Health and Family Welfare) in Modi 1.0 and MoS (Commerce & Industry) in Modi 2.0 Government. Smt. Patel graduated from Lady Shri Ram College of University of Delhi, holds an MBA degree from CSMJ University, Kanpur, Uttar Pradesh and PG Diploma in Counselling Psychology from Amity University, Noida.

Born on 28th April, 1981 at Kanpur, Uttar Pradesh, Smt. Anupriya Patel is a wellknown face of Indian politics. Her father, late Dr. Soney Lal Patel, was founder of Apna Dal, whose untimely demise in a road accident suddenly propelled her into political space.

Smt. Anupriya Patel, face of resurgence of the underprivileged, presents a strong image of a leader who is passionate, decisive and committed towards the cause of the oppressed and marginalised sections of the society and unparalleled spirit to work towards strengthening the social justice ideology.

Prof Amit Karna

PhD , Strategic Management

IIM Ahmedabad

Amit Karna is a Professor of Strategy and Dean of Alumni & External Relations at the Indian Institute of Management Ahmedabad (IIMA). He also serves on the IIMA Board of Governors.

Between 2015-2018, Karna chaired the Centre for Innovation Incubation and Entrepreneurship (now IIMA Ventures) one of the largest and most well-regarded educational institute based business incubators in Asia. He chaired the Business Policy Area at IIMA between 2017-2020, and served as Placements Chair of IIMA between 2018-2021 and Chairperson of PGPX (One Year MBA) between 2023-2026.

Karna's interests lie in the areas of strategy, technology management, innovation, and entrepreneurship. Karna is the faculty co-chair of Creative and Cultural Businesses Programme (https://ccbp.iima.ac.in/) and offers executive programmes on design thinking, innovation and corporate strategy topics. He has advised several organizations on strategy and management related issues.

Karna's research is in the fields of dynamic capabilities, innovation, and international strategy. He has presented several papers on these topics at various international conferences across the world. His research has been published in leading international journals such as Strategic Management Journal, Sloan Management Review, Journal of Management Studies, Long Range Planning, Corporate Governance: An International Review, Global Strategy Journal, R&D Management, Journal of International Management, and other international journals of repute.

Prior to IIMA, Karna was an Assistant Professor at EBS Business School in Germany between 2009 and 2014. He has been a visiting scholar at University of California at Berkeley's Haas School of Business in 2011, and at University of Sydney Business School in 2015 and 2023. He has been a visiting faculty at IESEG School of Management in France between 2012 and 2014. Karna completed his PhD in Strategy from IIMA. Prior to his doctorate, he worked with Aditya Birla Group in various managerial positions. 

Mr Manish Gupta

Manish Gupta is Co-founder, Chief Executive Officer and Chairman of Indegene. He has spearheaded the spectacular growth of Indegene from an initial Indian start-up to a globally respected technology-led healthcare solutions organization, leading the company to its Initial Public Offering (IPO) in 2024. He is acknowledged as a pioneer and thought leader in the global life sciences digital transformation space.  A BTech graduate from IIT-BHU, India, and a Master's in Business Administration from IIM Ahmedabad , India, he is the recipient of numerous prestigious awards- including the Young Alumni Achievers Award for Entrepreneurship from IIM Ahmedabad, India, and the Distinguished Alumnus Award from IIT-BHU, India. He was also a finalist in the EY Entrepreneur of the Year Awards 2022. Manish is a founder of Plaksha University, and a co-founder at the IIM Ahmedabad Endowment Fund.

Prof Bharat Bhasker

Director, Indian Institute of Management Ahmedabad

Prof. Bhasker obtained his Ph.D. and master’s degree in computer science at the Virginia Polytechnic Institute and State University, USA. He earned his Bachelor of Engineering from IIT Roorkee.

Prior to accepting the position of Director, IIM Ahmedabad, he served as a Professor of Information Technology and Systems at IIM Lucknow. He has also served as Director of IIM Raipur from March 2017 to March 2022, Acting-Director of IIM Lucknow during July 2015 to November 2015, as a Mentor Director/Convener (Nodal Prof.) at IIM Sirmaur in 2015. In 2018, he was honoured with 'Best Director of Business Schools' award for transforming IIM Raipur to a great place to work and its exponential growth. He was honoured with IIT Roorkee’s Distinguished Alumnus Award for 2022. In 2023, he received the ‘Kewal Nohriya Award for Academic Leadership in Management 2023’ at an event organized by the All India Management Association. In 2024, he received Dr. Pritam Singh Transformational Leader Award at an event organized by PRISM Foundation. In 2025, he received Bharat Asmita (National Award) Acharya Shreshtha Award – Best Teacher in Management at an event organised by MIT World Peace University, Pune. He also received Honorary Doctorate (Honoris Causa) from SRM Institute of Science and Technology, Tamil Nadu in 2025.

Prof. Bhasker has held various visiting academic positions such as International Expert Advisor at the University of Tenaga Nasional, Malaysia, International Expert,  Research Grants, at the Natural Sciences and Engineering Research Council of Canada  (NSERC), Visiting Professor at the ESSEC Business School, Paris, France,   Distinguished Professor at the Chung-Ang University, Seoul, Korea, Research  Professor at the University of California, USA, Visiting Professor at the University of Texas, USA and Adjunct Faculty at the University of Maryland, College Park.

Prof. Bhasker has acquired rich industry experience in addition to his academic experience. He has held senior positions at multiple organizations such as Connectix Corp., USA, SYBASE Inc., USA, MDL Information Systems Inc., USA, Hughes STX Inc., USA, and Tata Steel Ltd., India. He has also been associated as the Chairman at the Services Sector Development Council, Bureau of Indian Standards, President at the Indian Sub-continent Decision Science Institute, USA, Chairman at the Computer Society of India, Lucknow, Chairperson of the Governing Board of the INFLIBNET Centre. An Expert member of National Mission Authority of Pradhan Mantri Uchchatar Shiksha Abhiyan (PM-USHA) Chaired by the Minister of Education. A Member of Expert Committee to review University Grants Commission (Open and Distance Learning Programmes and Online Programmes) Regulations 2020. Chairperson of a Management Evaluation and Accreditation Committee (MEAC) of the National Board of Accreditation and as a Member of the Board of Governors at various organizations.

Ms Punya Srivastava

Ms. Punya Salila Srivastava joined the Indian Administrative Service (IAS) in 1993 and is currently Secretary in the Ministry of Health & Family Welfare (MoHFW), Government of India leading initiatives aimed at improving public health and healthcare delivery.  Before assumption of charge of Secretary in MoHFW, Ms. Srivastava was Officer-On-Special Duty in MoHFW, in the rank & pay of Secretary to Government of India.

Prior to joining MoHFW, Ms. Srivastava was Special Secretary in the Office of Prime Minister.

With a distinguished career spanning over 30 years in the Indian Administrative Service, Ms. Srivastava has held a range of crucial positions across various levels of governance. Ms Srivastava has served in pivotal roles, including Deputy Commissioner, Director, and Commissioner at the State and Union Territory levels. She has also made significant contributions as Joint Secretary and Additional Secretary in the Ministry of Home Affairs, and as Additional Secretary and Special Secretary in the Prime Minister’s Office.

In addition to her illustrious professional career, Ms. Srivastava is also a distinguished alumna of St. Stephen's College, University of Delhi. She completed both Graduation and Post-Graduation in Physics at this esteemed institution, laying a strong academic foundation that has complemented her public service career. She also has Masters in Public Management Degree from University of Maryland, USA.

Mr Pankaj Patel

Chairman
Zydus Lifesciences Limited

Mr Pankaj Patel is the Chairman of Zydus Lifesciences Ltd., a discovery-driven, global Lifesciences company with operations in 85 countries worldwide. A stalwart and a visionary, Mr. Pankaj Patel combines both research and techno-commercial expertise. He has published over 100 research papers in peer-reviewed journals and is a co-inventor in more than 64 patents. He has been conferred with Dsc. (Honoris Causa) by Dr A.P.J. Abdul Kalam Technical University, Lucknow.

Mr Patel is on the board of several institutions, including Chairman of the Board of Governors of IIM Ahmedabad, IIM Udaipur and Invest India. He is also a Member of the Governing Board of India Pharmacopoeia Commission (IPC) and a Member of the CEO Advisory Committee of International Generics and Biosimilars Association (IGBA). Mr. Patel is a Past President of the Federation of Indian Chamber of Commerce & Industry (FICCI). He also officiates on the board of several not-for-profit & charitable institutions. Mr. Patel is the Chairman of the GCS Foundation and the Gujarat Cancer and Research Institute. GCRI is a Regional Cancer Centre and one of the largest cancer centres of India, reaching out to the needy and underprivileged cancer patients. He also officiates as the Chairman of the Deaf and Mute School, Ahmedabad. He is also a Director and Chairman on the Board of Zydus Foundation which set up Zydus Hospital and Medical College, Dahod.

Mr. Pankaj Patel has been conferred with the prestigious Padma Bhushan for the year 2025 by the President of India. In recognition of his contributions to the healthcare industry in India, he has received several awards including the Acharya PC Ray Memorial Gold Medal Award and the Eminent Pharmacist Award, the India Innovator Award at the India Business Leaders Awards instituted by CNBC. For his entrepreneurial vision, Mr. Patel was awarded the Ernst & Young Entrepreneur of the Year Award in the Life Sciences category.

Mr Manoj Joshi

Secretary, Department of Pharmaceuticals
Ministry of Chemicals and Fertilizers, Government of India  

Shri Manoj Joshi graduated with a degree in Mechanical Engineering  and holds a master’s degree in economics. A member of the Indian  Administrative Service, Mr. Manoj Joshi started his career in 1989. Since  then, he has handled many positions and has vast experience across the  various sectors of Governance. In his bureaucratic journey, he has worked  with the State Government of Kerala and the Government of India.  

While in the State Government, he served as District Collector of  Kozhikode and held positions in General Administration Department, Health  & Family Welfare, Public Works Department and Finance Department. 

In the Centre, he served as a Director in Ministry of Commerce, Joint  Secretary in the Department of Personnel & Training, Department of  Economic Affairs, Ministry of MSME. He also worked as Counsellor in the  Embassy of India in Washington during the years 2004 – 2008. Later he  served as Additional Secretary / Special Secretary in the Ministry of Food  Processing Industries and held position as Secretary to Government of India  in the Ministry of Housing and Urban Affairs & Department of Land  Resources. 

Ms Priyanka Aggarwal

Managing Director & Senior Partner; Leader, Healthcare Practice, BCG India and South-East Asia 

Priyanka is a Managing Director & Senior Partner and leads BCG’s India and South East Asia Healthcare practice. She has 25 years of consulting experience and serves clients in Healthcare sector. She also leads DE&I agenda for BCG across Asia-Pacific, and is passionate about topic of diversity in leadership.

Across her consulting career, Priyanka has served clients across the healthcare spectrum – pharmaceutical companies, hospitals and medtech companies – on topics ranging from business strategy, operations transformation, procurement, sales and marketing and organisational effectiveness. Within industrial goods – she focuses on supply chain and data-driven analytics based performance improvement opportunities. 

Priyanka has worked across multiple geographies including India, US and SE Asia. She is known for her passion for client impact, pushing the performance trajectory of her clients and challenging the status-quo. 

She is the author many publications BCG Perspectives publication "Power to the Patient”, BCG-Mint collaboration on “Health Systems Leapfrogging in India: A need and a possibility. She is a regular speaker at Healthcare conferences and is a member of NATHEALTH. She was selected as one of Corporate India’s fastest rising women Leaders by Economic Times- Spencer Stuart in 2016.

Priyanka graduated from IIM Ahmedabad in 2000 as a Gold Medalist, and completed her B.E. in Electronics & Communication from Delhi University (also a University Gold Medalist).

Dr Rajeev Raghuvanshi

Dr Rajeev Singh Raghuvanshi has completed his Bachelors and Masters from IIT-BHU (Formerly IT-BHU), Varanasi and PhD from National Institute of Immunology, New Delhi. His PhD work is in the area of Extended Release Formulation of Vaccines, a project conceptualized to help reduce the number of injections required to be given for complete immunization. He has also done ISB-Kellogg Global Advanced Management Program.

After working for 7 yrs at National Institute of Immunology, New Delhi, Dr Rajeev moved to join the leading Indian multination, Ranbaxy Laboratories Ltd., where he worked for development, registration and launch of NDDS, Generics and Branded Generics in various global markets. After having spent 12 years with Ranbaxy, he moved to another Indian Multinational, Dr Reddy’s Laboratories Ltd, Hyderabad. In his 11 years of stay with Dr Reddy’s Labs, 1rst eight years was in development of 505b(2) NDA products for US market. In this role, he successfully led the CMC team to get 6 products approved in 1st review cycle by USFDA. During this tenure, he had the opportunity of multiple face to face interactions with USFDA, MHRA and agencies from South Korea, Sweden, Romania etc. Last three years at Dr Reddy’s has been in a different role of establishing an R & D Team for markets like India, China, Russia and other Emerging Markets in the space of Pharmaceutical Product Innovation / Differentiation, registration and launches. He is widely travelled throughout the world and has worked with team members and partners in countries like USA, UK, China, Russia, South Africa, Romania, Sweden, Canada, France, Australia and Japan. 

More than 200 products developed by him and his teams are currently being sold in India, US Europe and Emerging Markets. Dr Raghuvanshi has 19 granted US patents along with more than 250 published PCTs and Indian Patents. He has more than 70 publications in peer reviewed journals and has co-authored 6 chapters in books.  He has been visiting faculty at NIPER – Hyderabad and IIT-BHU and has taught students of NIPER-Mohali. He is a regular speaker at different International and National conferences on Pharmaceutical Innovation. For his contribution, Dr Reddy’s Labs has twice awarded him with “Dr Reddy’s Excellence Award”. 

Leadership development has been his passion and many of his team members mentored by him are holding leadership roles in Indian and global pharmaceutical companies. 

After a very successful career with corporate pharma, he decided to do something completely different which is socially more impactful. Of many possibilities, he chose to work with Govt. of India and joined Govt’s Ministry of Health and Family Welfare, as Secretary-cum-Scientific Director of Indian Pharmacopoeia Commission on 16 Feb’21. In a short stint of 2 yrs, he changed the face of IPC and bought multiple long lasting changes impacting quality standards for medicines being sold in India. Cultural shift to more open and receptive organization scaling up the Impurity Standards inventory, harmonization of quality specification with ICH and other global standards, increasing user base for IP and IPRS, PDG membership for IP, international recognitions and scaling up of Pharmacovigilane and Materiovigilance program of India are some of them. 

Govt of India has now given him the responsibility of Drugs Controller General of India. He joined the new position of 23rd Feb 2023 and working towards changes in India’s Drug Regulatory System for ease of doing business.  

In last 3 years, he has done signification intervention, to change the way CDSCO works and is perceived by stakeholders.  Some of the major changes brought forward are:

1. Notification of Revised Schedule-M
2. Waiver from T-Lic for Pre-clinical work
3. Waiver from BA/BE NOC for exports
4. Risk Based Inspections to improve quality of medicines being produced
5. In prinicipal agreement to involve Notified Bodies in some of the Regulatory activities
6. Agreement to develop internal scientific cadre in CDSCO with additional manpower

All these changes & interventions are going to have long lasting impact on Country’s Drug Regulatory System & Quality of Drugs being produced.        

Dr. Sunil Kumar Barnawal

Dr. Sunil Kumar Barnwal is a distinguished 1997-batch IAS officer of the Jharkhand cadre. He holds an engineering degree and a Master’s in Public Policy from the National University of Singapore and Harvard University. With over 21 years of extensive experience, his career has spanned various key roles within the Government of Jharkhand, including serving as Secretary for the Department of Industries, Mines & Geology, and as Secretary to the Chief Minister. His contributions cover a wide array of sectors, including education, IT, industry promotion, energy, natural resource management, and governance.

He previously held the position of Additional Secretary for the Department of Higher Education, Ministry of Education, Government of India. For the past three years, he has been working with the Government of India in Delhi, focusing on public policy and management particularly related to education, IT, Industry Promotion, Energy, Natural resource management and governance.

Currently, he serves as the Chief Executive Officer of the National Health Authority, under the Ministry of Health and Family Welfare, Government of India.

The National Health Authority (NHA) is the implementing body for two of India's flagship public health initiatives: the Ayushman Bharat Pradhan Mantri Jan Arogya Yojana (AB-PMJAY) and the Ayushman Bharat Digital Mission (ABDM). The NHA is responsible for the national rollout of both schemes, while State Health Agencies (SHAs), established as autonomous societies or trusts, manage their implementation at the state level.

Mr. Vivek Mohan

Vivek Mohan leads Abbott’s business in India, one of the country’s leading diversified healthcare companies, with responsibility for its pharmaceuticals business while also serving as the company’s Management Representative. Prior to this role, he led Global Corporate Marketing at Abbott’s headquarters in the United States, overseeing global brand strategy and architecture, corporate marketing, media, sponsorships, marketing excellence, and the company’s in-house creative agency.

Over a distinguished 30-year career with Abbott, Vivek has held senior leadership roles across the United States, India, Indonesia, the United Kingdom, and the Middle East. Combining deep commercial, strategic, and operational expertise, he has led business transformations, revitalized iconic brands, accelerated growth, and built high-performing organizations while helping shape innovative business models, strategic partnerships, and approaches that improve health outcomes in an evolving healthcare landscape.

Vivek holds a B.S. in Microbiology from the University of Michigan, an MBA from the University of Illinois, and completed the Chief Marketing Officer Program at Northwestern University. He has also served as faculty for strategy and business ethics.

Prof. Amit Sheth

Prof. Amit Sheth ( LinkedIn) is an Educator, researcher, and Entrepreneur. He is the Founding Director & CEO of the Indian AI Research Organisation (IAIRO, http://iairo.ai). He is the NCR Chair & Professor of Computer Science & Engg at the University of South Carolina. He grew the university-wide AI Institute of South Carolina (#AIISC) to nearly 50 researchers as its founding director in four years. His foundational AI research includes neuro-symbolic AI, emphasising trustworthy, explainable and safe AI, with translational applications to personalised and public health, biomedicine, social good and preventing social harm, including toxicity and misinformation, smart manufacturing, disaster management, etc. He is a fellow of the IEEE, AAAI, AAAS, ACM, and APAIA for his contributions to knowledge-enhanced computing, knowledge-based techniques to transform diverse data into insights and actions, distributed workflows and data semantics, data integration, etc. His major awards include the IEEE CS Wallace McDowell Award, IEEE TCSVC Research Innovation Award, Trustee Award, 10-year award (Intl Semantic Web Conf), OSU Franklin College Alumni Award, and Ohio Faculty Commercialisation Award (runner-up). In 2022, he was listed among the top 50/80 Computer Scientists in the USA/world h-index 124). Three of the AI companies he founded involved licensing his university research outcomes, and resulted in substantial income for the universities. These include the first Semantic Web company in 1999 that pioneered technology similar to what is found today in Google Semantic Search and Knowledge Graph, a clinical NLP company and a company (http://cognovilabs.com) at the intersection of emotion and AI. He is particularly proud of his >55 PhD students and postdocs’ exceptional success in academia, industry research labs, and as entrepreneurs.

Prof. Rajesh Chandwani

Fellow of IIM Bangalore, MD (Paediatrics)

Rajesh Chandwani is an Associate Professor in the Human Resource Management area and Co-Chairperson at the Centre for Management of Health Services at the Indian Institute of Management, Ahmedabad. He is a Fellow of IIM Bangalore. Previously, after completing his MD (Paediatrics) from Baroda Medical College, he served as a Paediatrician in public health institutions in remote rural and urban areas, primary and tertiary centres, and also rendered voluntary services for poor people through an NGO. Apart from clinical work, he was responsible for the implementation of health programs and integrated management systems in the hospital. He has published papers in national and international journals like IJHRM and IJTD. He has presented papers in various national and international conferences such as the Academy of Management, the European Group on Organisational Studies, the Indian Academy of Management, etc. He has a wide-ranging interest in human resource management issues and challenges in the Indian health care sector and HRM in the service sector. Specifically, current research interests include the use of Information technology to enhance the effectiveness of healthcare personnel and healthcare delivery, scaling up of affordable and quality healthcare services for the underprivileged.

Mr. Aman Mehta

Aman Mehta is the Managing Director of Torrent Pharmaceuticals Limited. He has been a key contributor in guiding strategic direction of the Company, with overall accountability for driving growth long term growth and strengthening market leadership in key territories.With an MBA from Columbia University, New York, and with over a decade of experience within the Torrent Group, Aman has held several leadership roles across the Power and Pharmaceutical businesses.He has been instrumental in accelerating the Company’s growth through a combination of organic initiatives and strategic acquisitions. His key contributions in the India business have been identification and integration of assets for M&A (JB, Unichem, Curatio etc) and driving organic growth in India led by field force expansion, in-licensing, and entry into new therapeutic areas.

Mr. Parijat Ghosh

APAC Practice Head: Healthcare & LifeSciences

Overall Summary

• 25+ years in consulting; Senior Partner and Leader in Bain’s APAC Leadership Council
• Expert in Healthcare & Life-Sciences, Parijat also has deep experience in Advanced Manufacturing
• Leadership roles in Bain across different parts of our business: industry, geography, capability and talent
• Significant experience in working with APAC champions and global MNCs across HQ and affiliate markets and financial investors across APAC

Select Experience

• Parijat has worked across Life-Sciences, Consumer Healthcare, API/ CDMO, Providers, Retail pharmacy, MedTech, Financial Investors and Health-Tech. Deep experience across the healthcare value chain in APAC and the US/ European pharmaceutical markets.
• Experienced in corporate & business unit strategy (incl. M&A and integration), revenue acceleration and operating model
• He has led several “Win with Customer (HCPs and Patients)” and “Win with Channels” programs, including digital/ GenAI led customer transformations with multiple pharmaceutical and provider companies
• Worked with multiple financial investors in multi-year transformation programs including commercial diligence and value creation (platform strategy, roll-up plays, intl. expansion, cost transformation, org. development)
• In addition, he has experience in manufacturing and operational transformation programs for Life-sciences players (formulations, API, CDMO) and Providers (tertiary care, retail health formats)
• Experience across Women’s Health, CVS/ Diabetes/ Obesity, Urology, Vaccines, Critical Care, Oncology, CNS and Rare Diseases

Sector engagement and Education

• Published extensively on healthcare sector topics; worked with different industry bodies NITI Aayog, IPA, IDMA, OPPI and NATHEALTH on a range of topics: Aarogya Bharat, Commercial models, Digital Disruption, Health-tech
• B. Tech (Hons) IIT, Kharagpur (1997) – Distinguished Alumnus Awardee (2025); MBA IIM Ahmedabad (1999)

Mr Amit gupta

As head of Corporate Strategy and Product at Indegene, Amit Gupta drives the company’s strategic growth priorities, including technology‑led transformation, long-term intellectual property builds as well as inorganic expansion. He collaborates with cross-functional teams at Indegene to support Indegene’s value as an integrated domain, AI and platform‑led life sciences partner to global Lifesciences organizations. He is an alumnus of IIT Kharagpur and IIM Ahmedabad.

Mr. Rizwan Koita

Rizwan is the Co-founder & Director of Koita Foundation & Chairperson of NABH, India's hospital accreditation organisation covering over 30,000 hospitals across India. Koita Foundation (KF) works at the intersection of digital technology and AI to strengthen India's healthcare and social sector ecosystem. KF has established CoEs in Digital Health & AI with leading institutions including IIT Bombay, Ashoka University, Tata Memorial/ National Cancer Grid (NCG), RSSDI (India’s largest Diabetes network with over 13,000 members), and FOGSI (India’s largest OBGY network with over 43,000 members). KF also supports national initiatives focused on Digital Health & AI capacity building, standards development and large-scale adoption.

​Mr. Koita was the Co-founder of CitiusTech (www.citiustech.com) and ran the company as CEO from 2005 to 2021. CitiusTech today have over 9,000 healthcare technology professionals and is India’s 25th Unicorn. He has a Bachelor's Degree in Engineering from IIT Bombay and a Master's Degree in Electrical Engineering and Computer Science from Massachusetts Institute of Technology (MIT).

Dr. Vishal Bali

Vishal Bali stands among Asia’s most influential healthcare leaders who has redefined how healthcare is delivered, scaled, and humanized across emerging and developed markets. Over a career spanning more than three decades, he has led a diversified group of healthcare enterprises across a spectrum of healthcare delivery organizations from hospitals to day care clinics across 12 countries in Asia Pacific.

As Executive Chairman of Asia Healthcare Holdings (AHH), Vishal leads the region’s first and largest single-speciality healthcare platform backed by global investors GIC and TPG Growth. Under his leadership, AHH has achieved transformative growth, creating healthcare enterprises which have become category leaders across Oncology, Mother & Childcare, Urology & Nephrology care and IVF. His work embodies a deep belief that the demand supply gap in healthcare can be filled by single-speciality healthcare at scale. Vishal is also Senior Advisor, TPG Growth

Previously, he served as the Global CEO of Fortis Healthcare managing a billion-dollar P&L across Asia Pacific and the CEO & Managing Director of Wockhardt Hospitals.

Vishal’s influence extends well beyond the corporate sphere. He sits on the boards of leading global healthcare organizations and has served as a member of the Strategic Initiatives Group of the Joint Commission International (USA) and the Global Agenda Council on Healthcare of the World Economic Forum. On the education side he has been involved with some of the case studies at Harvard Business School, underscoring his impact on global healthcare delivery models.

Beyond the boardroom, Vishal’s commitment to social equity finds expression in his work with the Neonates Foundation of India, which provides life-saving neonatal care to newborns from underprivileged families.

A sought-after global speaker and industry voice, Vishal continues to champion the transformation of healthcare through innovation, leadership and capital—building systems that deliver both clinical excellence and compassionate care.

Mr. Winselow Tucker

Winselow Tucker is President and General Manager at Eli Lilly and Company (India). Winselow oversees Lilly’s operations under the “One India” strategic framework, directing end-to-end commercial operations and leading the company’s sites in Bengaluru and Hyderabad—critical hubs that drive enterprise-wide innovation, digital solutions, and operational support for Lilly’s businesses across international markets.

 Winselow joined Lilly in 2022 as Group Vice President and Chief Commercial Officer of Lilly Oncology. In this role, he spearheaded global commercialization efforts and developed strategies for advancing Lilly’s oncology portfolio, focusing on innovative treatments in cancer care.

 Prior to joining Lilly, Winselow was Senior Vice President, Intercontinental, at Bristol Myers Squibb, where he oversaw a diverse region spanning more than 50 countries across five continents. Before joining Bristol Myers Squibb, Winselow held senior positions of increasing responsibility, leading teams in the U.S. and globally at Celgene and Novartis.

Mr. Rahul Guha

Mr Rahul Guha, MD & CEO of API Holdings Co. and Thyrocare Technologies, has guided its expansion to 31 labs across India and an international lab in Tanzania, supported by over 10,000 franchisees across 570 districts. The company now offers over 1,200 tests and profiles, operates with 73 pathologists, and holds 100% NABL accreditation across all labs (as on 5th Dec, 2024). He has also spearheaded the launches of ‘Jaanch’ and ‘Her Check’, achieving a 99%+ on-time sample collection rate. With deep expertise in digital incubation and product innovation, he has been a key contributor to advancing healthcare growth.

He is an IIM-B graduate with over 20 years of experience across HealthTech, MedTech, and Pharma. He spent 17 years at BCG, where he led Healthcare & Life Sciences as a Senior Partner. Earlier, he co-founded and served as CEO of Nautilus Software and was the CTO at ValuePay.com.

Prof. Trun Jain

Ms. Ameera Shah

Ameera Shah is the Promoter and Executive Chairperson of Metropolis Healthcare Limited, which she has transformed from a doctor-led practice into the second-largest diagnostic chain across India and Africa. Metropolis is the most respected scientific brand in diagnostics, operating in over 750 towns in India, trusted by doctors and serving tens of millions of patients each year. Over the past two decades, she has driven the company’s remarkable growth and corporate evolution, including raising three rounds of private equity funding and successfully taking Metropolis public in 2019, delivering industry-leading performance and strong returns for investors.

Ameera's achievements have been widely recognized through numerous awards and speaking invitations. She received the Ernst & Young ‘Entrepreneur of the Year’ Award in Healthcare in 2021. She is one of only three women to have received this award in the past 20 years and is the youngest woman ever to receive it. She has also been named one of ‘Asia’s Power Businesswomen’ by Forbes Asia and included among the ‘Fifty Most Powerful Women in Business’ by both Fortune India and Business Today.

Ameera Shah is a finance graduate from the University of Texas at Austin and an alumna of the Harvard Business School’s Owner/President Management Program (OPM). She serves on the boards of several leading companies, including Torrent Pharmaceuticals and ACC Limited (part of the Adani Group), and is a global advisor to prestigious universities and corporations. She has also held key leadership roles in several industry bodies, including having served as the youngest woman President of NATHealth (Healthcare Federation of India) last year, the apex organization driving healthcare policy and reforms in the country.

She is also the Co-founder and Chair of Women’s Entrepreneurship at the Udaiti Foundation, a nonprofit focused on unlocking women’s economic power in India through data-led policy, ecosystem partnerships, and enterprise solutions.

Dr. Sharvil Patel

Dr. Sharvil Patel is the Managing Director of Zydus Lifesciences Ltd., a global innovation-driven lifesciences company which has a legacy of over 70 years in the field of healthcare. The group was founded by Mr.Ramanbhai Patel in 1952. Today, the group researches, develops, manufactures and markets wide ranging therapeutics, biologicals and vaccines. Besides this, the group is into high-end diagnostics to detect cancers. Dr. Sharvil Patel, a third generation entrepreneur, also officiates as the Chairman on the Board of Zydus Wellness Ltd., which is creating several novel experiences for the health-conscious consumers and has a basket of niche products and iconic brands. With a specialisation in Chemical and Pharmaceutical Sciences from the University of Sunderland, U.K., and a doctorate also from the same university for his research work in Breast Cancer at Johns Hopkins, Bayview Medical Centre, USA, Dr. Sharvil combines both pharma and research expertise.

Dr. Sharvil Patel’s leadership has inspired the organisation to explore an expansive canvas of thoughts and ideas which are patient-centric, innovative and futuristic. With a turnover of over $2.75 bn, Zydus today has a global presence in over 90 countries worldwide including Asia, Europe, Latin America, MENA,North America. In the US and Europe, the group has been contributing to health and well-being since the last two decades.

As an innovation driven organisation, Zydus has been bringing in several novel NCEs, novel biologicals,biosimilars and vaccines to the market including the world’s first plasmid DNA vaccine ZyCoV-D to fight Covid-19. The group offers path-breaking discoveries for diseases such as Metabolic Associated Fatty Liver Disease (MAFLD), Metabolic dysfunction-associated Steato Hepatitis (MASH), Cancer, Chronic Kidney Disease, amongst others. Through its U.S. entity, the group also has an expanding portfolio focused on specialty and rare diseases. With a network of 44 manufacturing plants which includes 16 USFDA inspected facilities and 10 research and development centres, the group is powered by 30000 people worldwide. Dr. Sharvil Patel is also on the Board of Zydus Foundation which spearheads programmes related to healthcare, education,community development through livelihood programme and supporting grassroots innovation. Zydus Foundation supports the Zydus Medical College and Hospital which offers free of cost treatment to villagers in Dahod, a remote tribal village in Western Gujarat. At the 1034 bed hospital, all treatments and services are free of cost. More than 450,000 OPD patients avail treatment and more than 88000 surgeries are also conducted each year at the hospital.

Dr. Sharvil Patel is the Honorary Consul of Belgium and also the President of the Indian Pharmaceutical Alliance. He is an additional Independent Director of Gujarat Mineral Development Corporation Limited (GMDC). He is also a member of the BRICS Business Council – India Chapter. He has been conferred with the India’s Best CEOs - Services Vanguard Award – Pharmaceuticals & Healthcare by Business Today and Businessperson of Year Award by BioSpectrum for his contributions to the lifesciences sector. He has also been conferred the ET Pharmaleader of the year at the ET Healthworld India Pharma Awards 2022, ‘The Economic Times Most Promising Business Leaders of Asia 2020-21’ Award,’ GenNext Entrepreneur of the Forbes India Leadership Awards (FILA) 2020-21’ by the Forbes India and ‘Young Turks Award’ by India Pharma Awards 2021. He received the ‘40 Under 40 Most Influential Asians’ Award by the Asian Business & Social Forum 2018 (ABSF) and the Young Business Leader ’40 under Forty’ Award by ET Now in 2017

Mr Sudarshan Jain

Secretary General, Indian Pharmaceutical Alliance (IPA)
Chairman, Indian Institute of Health Management Research, Jaipur
Senior Advisor, EQT Group (Private Equity)
Visiting Faculty, Indian Institute of Management Ahmedabad (IIM A)

Overview
Sudarshan Jain is a healthcare industry leader with nearly 50 years of experience spanning pharmaceuticals, consumer healthcare (OTC), hospitals, diagnostics, and nutrition. He currently serves as Secretary General of the Indian Pharmaceutical Alliance (IPA), the association representing India's leading research-based pharmaceutical companies, and has a strong passion for business, healthcare policy, and the education sector. Widely recognised for his contributions to healthcare policy, industry development, and access to medicines, he is playing a pivotal role in shaping India's pharmaceutical ecosystem and strengthening its position as the “Pharmacy of the World.”

Board & Advisory Roles
• Board Member, Abbott India, Sunshine Healthcare, Encube and various educational institutions
• Member of national advisory bodies – Drugs Technical Advisory Board (DTAB) and the Biotechnology Ignition Grant (BIG) Advisory Committee – of the Government of India

Professional Experience
Before joining IPA in 2019, Sudarshan held several leadership positions in Abbott, J&J, Boots and leading Indian companies and last served as the Managing Director, Abbott Healthcare Solutions. His career has involved building and scaling pharmaceutical and healthcare businesses, developing high-impact brands, and driving industry transformation. He has been associated with over 30 brands that rank among the top 300 in the Indian pharmaceutical market. Until recently, he was a Senior Advisor with APAX Partners and a board member of Healthium.

Leadership & Industry Contributions
Sudarshan has been a strong advocate for affordable access to medicines, quality enhancement, innovation-led growth anchored in regulatory and policy reforms, and industry capability building. • Chair, International Generic and Biosimilar Medicines Association (IGBA) – 2021
• Chairman, Life Sciences Sector Skill Development Council (LSSSDC), under the Ministry of Skill Development & Entrepreneurship, Government of India – 2022-24
• Certified Executive Coach, Coaching Foundation of India

Awards & Recognition
• First Indian recipient of the Global Chairman's Award at Abbott
• Under his leadership, IPA received the inaugural “Maverick Effect Pioneer Award 2024” from the Indian Merchants' Chamber (IMC) and the “Best Association Excellence Award” at the India Association Congress 2024

Education
Sudarshan is an alumnus of St. Stephen's College, Delhi (B.Sc. Hons.) and the Indian Institute of Management Ahmedabad (PGDM).